Capital Advantage, Inc. has filed its 13F form on November 07, 2024 for Q3 2024 where it was disclosed a total value porftolio of $520 Million distributed in 49 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Vanguard Intermediate Term Cor with a value of $108M, Schwab Fundamental Intl Large with a value of $53.3M, Vanguard Whitehall Fds Intl Di with a value of $35.7M, Vanguard Whitehall Fds Intl Hi with a value of $30.1M, and Vanguard Health Care ETF with a value of $25.7M.

Examining the 13F form we can see an increase of $36.3M in the current position value, from $483M to 520M.

Below you can find more details about Capital Advantage, Inc. portfolio as well as his latest detailed transactions.

Portfolio value $520 Million
ETFs: $471 Million
Technology: $35.9 Million
Financial Services: $4.77 Million
Energy: $3.52 Million
Consumer Cyclical: $2.29 Million
Communication Services: $1.05 Million
Healthcare: $587,000
Consumer Defensive: $443,000
Other: $0

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 49
  • Current Value $520 Million
  • Prior Value $483 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 07, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 2 stocks
  • Additional Purchases 20 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 23 stocks
Track This Portfolio

Track Capital Advantage, Inc. Portfolio

Follow Capital Advantage, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advantage, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital Advantage, Inc. with notifications on news.